In 2022, citing shortages of the drugs, the FDA allowed compounding pharmacies to make them but with the shortages over, the FDA stopped allowing compounding pharmacies to make tirzepatide (Mounjaro and Zepbound) in March, and semaglutide (Ozempic and Wegovy) last week
Ozempic (semaglutide) has dominated the GLP-1 market due to its early approval, strong efficacy in glycemic control, and weekly administration convenience
GLP-1 medications aren't appropriate for everyone, and the evaluation determines whether they're right for you
Cardiovascular Risks of GLP-1 Medications GLP-1 receptor agonists, like semaglutide, liraglutide, dulaglutide, and tirzepatide, are widely used for managing type 2 diabetes and obesity
Your weight loss journey can benefit from the bioactive compounds in this helpful plant that aid in regulating blood sugar and energy levels while reducing cravings and boosting your natural metabolic abilities